Annual ROE
49.73%
-34.15%-40.71%
December 31, 2023
Summary
- As of February 21, 2025, BCRX annual return on equity is 49.73%, with the most recent change of -34.15% (-40.71%) on December 31, 2023.
- During the last 3 years, BCRX annual ROE has risen by +1975.10% (+102.58%).
- BCRX annual ROE is now -98.14% below its all-time high of 2673.89%, reached on December 31, 2013.
Performance
BCRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
26.40%
-5.70%-17.76%
September 30, 2024
Summary
- As of February 21, 2025, BCRX quarterly return on equity is 26.40%, with the most recent change of -5.70% (-17.76%) on September 30, 2024.
- Over the past year, BCRX quarterly ROE has dropped by -30.82% (-53.86%).
- BCRX quarterly ROE is now -97.89% below its all-time high of 1254.11%, reached on December 31, 2013.
Performance
BCRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
BCRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.7% | -53.9% |
| 3 y3 years | +102.6% | -89.9% |
| 5 y5 years | +132.7% | +103.7% |
BCRX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -71.1% | at low | -84.4% | at low |
| 5 y | 5-year | -71.1% | +102.6% | -94.9% | +100.5% |
| alltime | all time | -98.1% | +102.6% | -97.9% | +100.1% |
BioCryst Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 26.40%(-17.8%) |
| Jun 2024 | - | 32.10%(-33.4%) |
| Mar 2024 | - | 48.19%(-15.8%) |
| Dec 2023 | 49.73%(-40.7%) | 57.22%(-13.9%) |
| Sep 2023 | - | 66.46%(-14.1%) |
| Jun 2023 | - | 77.41%(-7.7%) |
| Mar 2023 | - | 83.89%(-22.4%) |
| Dec 2022 | 83.88%(-51.2%) | 108.06%(+1.6%) |
| Sep 2022 | - | 106.37%(-19.9%) |
| Jun 2022 | - | 132.79%(-10.3%) |
| Mar 2022 | - | 147.98%(-12.6%) |
| Dec 2021 | 172.04%(-108.9%) | 169.22%(-35.2%) |
| Sep 2021 | - | 261.14%(-49.2%) |
| Jun 2021 | - | 513.75%(-109.6%) |
| Mar 2021 | - | -5360.22%(+678.6%) |
| Dec 2020 | -1925.37%(+673.4%) | -688.40%(+22.1%) |
| Sep 2020 | - | -563.87%(-34.2%) |
| Jun 2020 | - | -856.52%(-79.3%) |
| Mar 2020 | - | -4134.45%(+352.2%) |
| Dec 2019 | -248.94%(+63.5%) | -914.36%(+28.8%) |
| Sep 2019 | - | -709.93%(+105.1%) |
| Jun 2019 | - | -346.11%(+64.3%) |
| Mar 2019 | - | -210.65%(+30.7%) |
| Dec 2018 | -152.26%(-1.2%) | -161.17%(+26.2%) |
| Sep 2018 | - | -127.72%(+2.5%) |
| Jun 2018 | - | -124.56%(-0.4%) |
| Mar 2018 | - | -125.12%(-5.4%) |
| Dec 2017 | -154.16%(-31.1%) | -132.31%(-12.0%) |
| Sep 2017 | - | -150.29%(-48.0%) |
| Jun 2017 | - | -288.95%(+5.9%) |
| Mar 2017 | - | -272.79%(-6.5%) |
| Dec 2016 | -223.70%(+220.7%) | -291.83%(+33.2%) |
| Sep 2016 | - | -219.11%(+39.7%) |
| Jun 2016 | - | -156.89%(+73.4%) |
| Mar 2016 | - | -90.50%(+38.0%) |
| Dec 2015 | -69.75%(-42.5%) | -65.60%(+30.5%) |
| Sep 2015 | - | -50.27%(+27.8%) |
| Jun 2015 | - | -39.35%(-51.8%) |
| Mar 2015 | - | -81.57%(-12.5%) |
| Dec 2014 | -121.30%(-104.5%) | -93.24%(-18.6%) |
| Sep 2014 | - | -114.48%(-53.5%) |
| Jun 2014 | - | -246.23%(-121.5%) |
| Mar 2014 | - | 1144.93%(-8.7%) |
| Dec 2013 | 2673.89%(-591.0%) | 1254.11%(-106.0%) |
| Sep 2013 | - | -20.94 K%(+1366.3%) |
| Jun 2013 | - | -1428.45%(+244.8%) |
| Mar 2013 | - | -414.30%(+33.5%) |
| Dec 2012 | -544.61%(+284.0%) | -310.44%(+34.7%) |
| Sep 2012 | - | -230.43%(+19.2%) |
| Jun 2012 | - | -193.31%(+21.8%) |
| Mar 2012 | - | -158.72%(+11.4%) |
| Dec 2011 | -141.82%(+217.9%) | -142.53%(+37.0%) |
| Sep 2011 | - | -104.03%(+30.9%) |
| Jun 2011 | - | -79.46%(+30.3%) |
| Mar 2011 | - | -60.97%(+42.4%) |
| Dec 2010 | -44.61%(+120.1%) | -42.82%(+255.9%) |
| Sep 2010 | - | -12.03%(-9.7%) |
| Jun 2010 | - | -13.32%(+4.6%) |
| Mar 2010 | - | -12.74%(-57.2%) |
| Dec 2009 | -20.27% | -29.75%(-43.9%) |
| Sep 2009 | - | -53.02%(+21.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2009 | - | -43.63%(-9.7%) |
| Mar 2009 | - | -48.31%(-5.1%) |
| Dec 2008 | -44.43%(-34.2%) | -50.89%(-28.1%) |
| Sep 2008 | - | -70.73%(-14.4%) |
| Jun 2008 | - | -82.61%(+3.1%) |
| Mar 2008 | - | -80.09%(-3.5%) |
| Dec 2007 | -67.52%(-38.4%) | -83.01%(-36.8%) |
| Sep 2007 | - | -131.39%(-24.6%) |
| Jun 2007 | - | -174.26%(+27.3%) |
| Mar 2007 | - | -136.87%(+30.1%) |
| Dec 2006 | -109.60%(+84.3%) | -105.24%(+13.9%) |
| Sep 2006 | - | -92.36%(+30.4%) |
| Jun 2006 | - | -70.83%(+16.7%) |
| Mar 2006 | - | -60.69%(-2.5%) |
| Dec 2005 | -59.47%(-18.6%) | -62.27%(-4.7%) |
| Sep 2005 | - | -65.33%(+13.7%) |
| Jun 2005 | - | -57.44%(+4.2%) |
| Mar 2005 | - | -55.15%(-8.6%) |
| Dec 2004 | -73.05%(+97.2%) | -60.32%(+11.6%) |
| Sep 2004 | - | -54.04%(+10.9%) |
| Jun 2004 | - | -48.73%(+10.4%) |
| Mar 2004 | - | -44.12%(+18.8%) |
| Dec 2003 | -37.04%(+6.0%) | -37.15%(+13.0%) |
| Sep 2003 | - | -32.87%(+8.2%) |
| Jun 2003 | - | -30.37%(-6.1%) |
| Mar 2003 | - | -32.35%(-9.3%) |
| Dec 2002 | -34.93%(+314.4%) | -35.66%(-3.6%) |
| Sep 2002 | - | -37.01%(+33.8%) |
| Jun 2002 | - | -27.66%(+74.7%) |
| Mar 2002 | - | -15.83%(+91.4%) |
| Dec 2001 | -8.43%(-51.6%) | -8.27%(+182.3%) |
| Sep 2001 | - | -2.93%(-41.0%) |
| Jun 2001 | - | -4.97%(-39.0%) |
| Mar 2001 | - | -8.15%(-50.6%) |
| Dec 2000 | -17.43%(+62.9%) | -16.50%(+2.3%) |
| Sep 2000 | - | -16.13%(-23.8%) |
| Jun 2000 | - | -21.16%(-9.3%) |
| Mar 2000 | - | -23.34%(+53.8%) |
| Dec 1999 | -10.70%(-40.9%) | -15.18%(-40.3%) |
| Sep 1999 | - | -25.42%(+309.3%) |
| Jun 1999 | - | -6.21%(-65.0%) |
| Mar 1999 | - | -17.74%(-12.6%) |
| Dec 1998 | -18.11%(-48.2%) | -20.29%(-22.3%) |
| Sep 1998 | - | -26.12%(-42.0%) |
| Jun 1998 | - | -45.06%(+19.5%) |
| Mar 1998 | - | -37.72%(+8.0%) |
| Dec 1997 | -34.93%(+5.9%) | -34.91%(+14.2%) |
| Sep 1997 | - | -30.57%(-6.4%) |
| Jun 1997 | - | -32.67%(+0.6%) |
| Mar 1997 | - | -32.48%(-2.3%) |
| Dec 1996 | -32.98%(-56.9%) | -33.25%(-19.9%) |
| Sep 1996 | - | -41.53%(-13.0%) |
| Jun 1996 | - | -47.75%(-17.2%) |
| Mar 1996 | - | -57.66%(-20.1%) |
| Dec 1995 | -76.44%(+24.1%) | -72.15%(+7.9%) |
| Sep 1995 | - | -66.88%(+2.4%) |
| Jun 1995 | - | -65.29%(-4.8%) |
| Mar 1995 | - | -68.56%(+27.9%) |
| Dec 1994 | -61.61% | -53.59%(+41.1%) |
| Sep 1994 | - | -37.97%(+48.1%) |
| Jun 1994 | - | -25.64%(+133.9%) |
| Mar 1994 | - | -10.96% |
FAQ
- What is BioCryst Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual ROE year-on-year change?
- What is BioCryst Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly ROE year-on-year change?
What is BioCryst Pharmaceuticals annual return on equity?
The current annual ROE of BCRX is 49.73%
What is the all time high annual ROE for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual return on equity is 2673.89%
What is BioCryst Pharmaceuticals annual ROE year-on-year change?
Over the past year, BCRX annual return on equity has changed by -34.15% (-40.71%)
What is BioCryst Pharmaceuticals quarterly return on equity?
The current quarterly ROE of BCRX is 26.40%
What is the all time high quarterly ROE for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly return on equity is 1254.11%
What is BioCryst Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, BCRX quarterly return on equity has changed by -30.82% (-53.86%)